Professor, Division of Maternal-Fetal Medicine in the Department of Obstetrics and Gynecology, and Reproductive Sciences and in the Department of Pediatric Surgery
The John P. and Kathrine G. McGovern Medical School at The University of Texas Health Science Center
Co-director, The Fetal Center
Children’s Memorial Hermann Hospital
Dr. Anthony Johnson is an internationally renowned specialist in maternal-fetal medicine (MFM). He has performed more than 300 laser ablation procedures in the treatment of severe twin-to-twin transfusion syndrome, and has extensive experience with other fetoscopic-based and needle guided in utero procedures.
He received his medical degree from the West Virginia School of Osteopathic Medicine in Lewisburg, West Virginia, and subsequently completed his fellowship in Maternal-Fetal Medicine at Pennsylvania Hospital in Philadelphia and a fellowship in medical genetics at Thomas Jefferson University Hospital in Philadelphia. He later served as the director of the Fetal Intervention Program in the Division of Maternal Fetal Medicine at North Carolina Women’s Hospital in Chapel Hill, North Carolina prior to relocating to Houston in 2006.
Dr. Johnson joined the The Fetal Center, affiliated with Children’s Memorial Hermann Hospital and McGovern Medical School at UTHealth, in 2011 as co-director. Prior to joining the team, he was a professor in the Department of Obstetrics and Gynecology, the Michael E. DeBakey Department of Surgery and the Department of Molecular and Human Genetics at Baylor College of Medicine in Houston. He was also one of the senior MFM physicians as part of the Texas Children’s Fetal Center team.
He has served as director of the Society for Maternal-Fetal Medicine’s Special Interest Group in Maternal-Fetal Surgery and Special Interest Group in Genetics. He is an examiner on the Maternal Fetal Medicine Subspecialty Committee of the American Osteopathic Board of Obstetrics and Gynecology, and on the Medical Advisory Board of the Fetal Health Foundation.
Dr. Johnson was a reviewer of the National Institutes of Child Health and Human Development (NICHD), which sponsored the Management of Myelomeningocele Study (MOMS), that was published in the New England Journal of Medicine in 2011. Dr. Johnson’s specialty interests include:
Complicated Monochorionic Multifetal pregnancies Twin-Twin transfusion syndrome (TTTS)
Selective fetal growth restriction (SIUGR)
Other fetoscopic-based and needle guided in utero procedures including:
– Laser for TTTS
– Tracheal occlusion for diaphragmatic hernia
– Vesico-amniotic and pleura-amniotic shunts
Medical Director, Special Delivery Unit
Center for Fetal Diagnosis and Treatment
The Children’s Hospital of Philadelphia
Dr. Julie Moldenhauer is an Attending Physician at the Center for Fetal Diagnosis and Treatment at Children’s Hospital of Philadelphia (CHOP), and Medical Director of the Garbose Family Special Delivery Unit. Her clinical focus is in prenatal diagnosis and fetal therapy. She cares for mothers carrying babies with fetal anomalies that place both mother and baby at high risk.
One of Dr. Moldenhauer’s research interests lies in improving the prenatal management of gastroschisis, a defect that causes the fetal intestines to extend into the amniotic fluid through an opening in the abdominal wall. Dr. Moldenhauer also has a particular interest in outcomes after open fetal surgery and EXIT procedures, examining how fetal conditions and their treatment can place mothers at increased risk for complications. She believes that with a better understanding of the interrelation of mother and baby, we can improve the outcome for both.
Before joining CHOP in 2009, Dr. Moldenhauer was the Director of Reproductive Genetics in the Division of Maternal Fetal Medicine at the University of North Carolina. Her extensive background in reproductive genetics gives her unique insight into the practice of prenatal diagnosis.
“I tell every patient that our job is to teach them everything they need to know about their baby’s condition. We need to give them the tools to help them feel comfortable making the best care decisions possible,” Dr. Moldenhauer says. “I speak to patients and families the way I would want to be spoken to myself — I am a mom, too.”
Dr. Moldenhauer has great compassion for her patients and their families, and is interested in how a prenatal diagnosis affects the mother from a psychological standpoint. “I hope to build on caring for the mental well-being of these families,” she says.
Dr. Moldenhauer is conducting further studies into post-partum depression as it relates to mothers carrying babies with fetal anomalies, with the goal of integrating that learning into patient care. “If we can define how often depression occurs and create management strategies to help women and their families, we may be able to make a significant impact.”
Dr. Moldenhauer earned her BS degree in chemistry from Hillsdale College and her medical degree from Wayne State University, both in Michigan. She performed her residencies in obstetrics and gynecology and human genetics at Wayne State University. She also completed her fellowship in maternal-fetal medicine at Wayne State University . She is board certified in obstetrics & gynecology, maternal-fetal medicine and clinical genetics.
In spring 2015, Dr. Moldenhauer appeared in a three-part documentary series airing on PBS called TWICE BORN: Stories from the Special Delivery Unit. The Emmy® Award-winning documentary offered a look inside the Center for Fetal Diagnosis and Treatment at Children’s Hospital of Philadelphia, and its unique Garbose Family Special Delivery Unit.
Senior Associate Consultant
Chair, Division of Maternal-Fetal Medicine
Professor of Obstetrics & Gynecology and Physiology & Biomedical Engineering
Mayo Clinic College of Medicine
His medical degree was from Medical School of University of São Paulo, São Paulo, Brazil (1992-1997). He completed his residency Hospital das Clinicas Medical School of University of São Paulo, São Paulo, Brazil (1998-2001). Additional training included a Maternal-Fetal Medicine fellowship at Hôpital Necker-Enfants Malades, AP-HP, Université de Paris V, Paris, France (2001-2003) and Fetal Surgery fellowship at Centre Hospitalier Intercommunal Saint-Germain-en-Laye, Université de Versailles Saint-Quentin-em-Yvelines, France (2003-2004). He concluded his PhD thesis “Evaluation of lung volumes by 3D-ultrasonography in fetuses with diaphragmatic hernia congenital isolation” at Medical School of University of São Paulo, São Paulo, Brazil in 2005.
Dr. Ruano has authored over 170 peer-reviewed articles (PUBMED) and 50 book chapters pertaining to maternal-fetal medicine, prenatal detection of congenital anomalies, 3D/4D fetal ultrasonography, and fetal surgery.
Dr. Ruano focuses his clinical efforts on developing and investigating new minimally invasive fetal therapies such as fetal endoscopic tracheal occlusion (FETO) for congenital diaphragmatic hernia, fetal cystoscopy for fetal bladder obstruction and fetoscopic laser ablation for twin-twin transfusion syndrome.
Associate Professor, Department of Obstetrics, Gynecology, & Reproductive Sciences, Divisions of Ultrasound and Maternal-Fetal Medicine
Director, Center for Innovative Fetal Intervention at Magee-Womens Hospital of UPMC
University of Pittsburgh School of Medicine
Dr. Emery is the Director of the Center for Innovative Fetal Intervention at Magee-Womens Hospital of UPMC. He is the principal provider of fetal therapy for this geographic region. He is the main instructor on fetal therapy for Maternal-Fetal Medicine fellows, Ob/Gyn residents and medical students. Dr. Emery is the Chair of the Steering Committee of the North American Fetal Therapy Network (NAFTNet) and is responsible for its research agenda. He has recently conducted a multinational, multicenter, multidisciplinary study on the treatment of early-stage twin-twin transfusion syndrome (TTTS) which was published in a major medical journal and presented ant the 36th International Fetal Medicine and Surgery Society (IFMSS) meeting in August of 2016. Dr. Emery is leading an international evidence-based reassessment of ventriculoamniotic shunting for fetal severe hydrocephalus through NAFTNet and IFMSS. His clinical, research and education efforts revolve around fetal therapy.